1-5 of 5
Howard S. Hochster
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials

Clinical Trials & Observations
Carla Casulo, Jesse G. Dixon, Jennifer Le-Rademacher, Eva Hoster, Howard S. Hochster, Wolfgang Hiddemann, Robert Marcus, Eva Kimby, Michael Herold, Catherine Sebban, Emmanuel Gyan, Kenneth Foon, Tina Nielsen, Umberto Vitolo, Gilles A. Salles, Qian Shi, Christopher R. Flowers
Journal: Blood
Blood (2022) 139 (11): 1684–1693.
https://doi.org/10.1182/blood.2020010263
Published: 2022
Includes: Supplemental data
Journal Articles

Outcomes for Elderly Patients (pts) with Follicular Lymphoma (FL) Using Individual Patient Data (IPD) from 5922 Pts in 18 Randomized Controlled Trials (RCTs): a Follicular Lymphoma Analysis of Surrogate Hypothesis (FLASH) Group Study

Christopher Flowers, MDMS, Fang-Shu Ou, PhD, Qian Shi, PhD, Eva Hoster, PhD, Bruce A. Peterson, MD, Howard S. Hochster, MD, Pauline Brice, MD, Marco Ladetto, MD, Wolfgang Hiddemann, MD, Robert E Marcus, Eva Kimby, MD PhD, Michael Herold, Sabine De Bedout, MD MPH, Tina Nielsen, Franck Morschhauser, Mathias Rummel, MD PhD, Anton Hagenbeek, MD PhD, Umberto Vitolo, Gilles A. Salles, Daniel Sargent, PhD
Journal: Blood
Blood (2016) 128 (22): 1102.
https://doi.org/10.1182/blood.V128.22.1102.1102
Published: 2016
Journal Articles

The Role Of Body Mass Index In Survival Outcome For Lymphoma Patients: US Intergroup Experience

Fangxin Hong, Ph.D., Thomas M Habermann, MD, Leo I. Gordon, MD, Howard S Hochster, MD, Randy D. Gascoyne, MD, Vicki A. Morrison, MD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Patrick J Stiff, MD, Bruce D. Cheson, M.D., Michael Crump, MD FRCPC, Sandra J. Horning, MD, Brad S. Kahl, MD
Journal: Blood
Blood (2013) 122 (21): 3060.
https://doi.org/10.1182/blood.V122.21.3060.3060
Published: 2013
Journal Articles

Differences in Outcomes in Males and Females with Diffuse Large B-Cell Lymphoma with Induction Rituximab and Follicular Lymphoma Treated with Maintenance Rituximab

Thomas M Habermann, MD, Fangxin Hong, PhD, Vicki A. Morrison, MD, Shaker R. Dakhil, MD, James K. Weick, MD, Stanley R. Frankel, MD, Randy D. Gascoyne, MD, Richard I Fisher, MD, Bruce D. Cheson, MD, Edie A. Weller, PhD, Brad S. Kahl, M.D., Bruce A. Peterson, MD, Howard S Hochster, MD, Sandra J. Horning, M.D.
Journal: Blood
Blood (2012) 120 (21): 3705.
https://doi.org/10.1182/blood.V120.21.3705.3705
Published: 2012
Journal Articles

Maintenance Rituximab after CVP Results in Superior Clinical Outcome in Advanced Follicular Lymphoma (FL): Results of the E1496 Phase III Trial from the Eastern Cooperative Oncology Group and the Cancer and Leukemia Group B.

Howard S. Hochster, MD, Edie Weller, PhD, Randy D. Gascoyne, MD, Teresa S. Ryan, MD, Thomas M. Habermann, MD, Leo I. Gordon, MD, Stanley R. Frankel, MD, Sandra J. Horning, MD
Journal: Blood
Blood (2005) 106 (11): 349.
https://doi.org/10.1182/blood.V106.11.349.349
Published: 2005